tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Harrison, 368 are a BUY (61.13%), 171 are a HOLD (28.41%), 63 are a SELL (10.47%).
Analyst Matthew Harrison, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 66.78% that have a potential upside of 29.46% achieved within 202 days.
Matthew Harrison’s has documented 1,393 price targets and ratings displayed on 88 stocks. The coverage is on Healthcare, Technology, Basic Materials, Energy sectors.
Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 01-Oct-2024.
Analyst best performing recommendations are on CMRX (CHIMERIX).
The best stock recommendation documented was for CMRX (CHIMERIX) at 2/23/2016. The price target of $5 was fulfilled within 1 day with a profit of $0.54 (12.11%) receiving and performance score of 121.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$8
$4.71 (143.16%)
$8
2 months 1 days ago
1/10 (10%)
$5.19 (184.70%)
70
Buy
$8
$4.71 (143.16%)
$8
2 months 2 days ago
0/7 (0%)
$5.26 (191.97%)
Sell
$1
$-2.29 (-69.60%)
$2
11 months 22 days ago
2/4 (50%)
$0.23 (29.87%)
30
Hold
$5
1 years 1 months 29 days ago
1/2 (50%)
$-0.07 (-1.38%)
2
Buy
$10
1 years 2 months ago
0/4 (0%)
$7.6 (316.67%)
Which stock is Matthew Harrison is most bullish on?
Which stock is Matthew Harrison is most reserved on?
What Year was the first public recommendation made by Matthew Harrison?
